Oelschlager Kristen M sold $149K of CSTL
Oelschlager Kristen M (Chief Operating Officer) sold 4,153 shares of CASTLE BIOSCIENCES INC (CSTL) at an average of $35.95 ($35.75–$36.38, $0.15M total) across 2 trades on 2026-10-01 under a Rule 10b5-1 trading plan.
How this was made
The 30-second read
Why it matters
The filing provides the first public disclosure of this insider sell, offering a data point for traders monitoring insider sentiment.
Market read
A modest insider sell by a senior officer, disclosed via Form 4, may cause slight short‑term pressure but is unlikely to move the stock materially.
What to watch
The sale price was near recent trading levels, suggesting no discount.
Background
Castle Biosciences (CSTL) is a Nasdaq‑listed biotech focused on cancer diagnostics. Insider transactions are disclosed via Form 4.
Ticker impact
COO Kristen Oelschlager sold 4,153 shares for $149,317 via a 10b5‑1 plan, reducing her stake to 13,356 shares.
likely slight downward pressure as the market prices the insider sell.
A 10b5‑1 sale by a senior officer, though modest in size, can be interpreted as a lack of confidence, prompting short‑term sellers.
Market effects
Minimal impact on the broader biotech sector.
No significant regional effect.
Limited to investors tracking insider activity.
Counterpoint
The sale could be routine portfolio rebalancing, not a negative signal.
Key entities
- CompanyCastle Biosciences Inc.
Biotech firm developing diagnostic tests.
- ExecutiveKristen M. Oelschlager
Chief Operating Officer of Castle Biosciences.
